Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study.Ulrich Keilholz, Jérôme Fayette, Michael Schenker et al.|Journal of Clinical Oncology|2018Cited by 5
Une grosse verge douloureuseM. Dupin, P. Combemale, Danijela Rabar et al.|La Revue de Médecine Interne|2002Cited by 1